Patient webinar: Introducing PoNS, a neuromodulation therapy for people with multiple sclerosis (MS)

For general inquiries, call 1 877-564-0008 or [email protected]. Fax PoNS device prescriptions to 1 (215) 754-4903.

Join Helius’ Chief Medical Officer Antonella Favit Van-Pelt, who will discuss the science behind PoNS, and Patient Ambassador, Kerrie Walters, who will highlight her experience during and after completing PoNS Therapy™.

Date: Wednesday, August 30, 2023

Time: 6:00 pm-7:00 pm EDT

Webinar intended for US residents only.

For Patients

For general inquiries, contact us by phone at 1 877-564-0008 or via email at [email protected].

Please fax PoNS device prescriptions to 1 (215) 754-4903.

NASDAQ: HSDT

Indications

The PoNS^® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.

Contraindications

The PoNS^® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).

Electrical stimulation should not be used:

If there is an active or suspected malignant tumor
In areas of recent bleeding or open wounds
In areas that lack normal sensation

The PoNS^® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS^® if you are sensitive to nickel, gold or copper.

Patient webinar: Introducing PoNS, a neuromodulation therapy for people with multiple sclerosis (MS)

For Patients

Indications

Contraindications

Ready to get started with PoNS?